Thioridazine 25 MG Oral Tablet — RxCUI 198274
RxNorm drug concept · Semantic clinical drug
RxCUI 198274
Semantic clinical drug · SCD
● Current RxNorm concept 20 FDA products
29 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI198274
Official nameThioridazine 25 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asthioridazine (as thioridazine hydrochloride) 25 MG Oral Tablet; thioridazine HCl 25 MG Oral Tablet
FDA products mapped20
Package NDCs mapped29
Reported Medicaid activity (SDUD)2,959 prescriptions · 16 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Thioridazine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Thioridazine is reserved for people with schizophrenia who have already tried at least two other antipsychotic medications without good results — either because they didn't work we...
- Why am I on thioridazine instead of a more common antipsychotic?
- Thioridazine can affect your heart's electrical system and, in some cases, trigger a dangerous arrhythmia called Torsades de pointes. Go to the emergency room right away — or call...
- What heart-related risks should I know about, and what symptoms should send me to the ER?
🕸️ Concept Web — How Thioridazine 25 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Thioridazine 25 MG Oral Tablet
RxCUI 198274 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Thioridazine
10502IN
-
Thioridazine
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Thioridazine Oral Tablet
374108SCDF -
Thioridazine Oral Product
1165534SCDG -
Thioridazine Pill
1165535SCDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Thioridazine Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Thioridazine 25 MG
328706SCDC
-
Thioridazine 25 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Thioridazine 25 MG
SCDC · 328706 -
Thioridazine Oral Tablet
SCDF · 374108 -
Thioridazine Oral Product
SCDG · 1165534 -
Thioridazine Pill
SCDG · 1165535
📦 FDA Products & Package NDCs
20 products · 29 package NDCs
29 package NDCs map to RxCUI 198274 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00378-0612-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0612-01) | Thioridazine Hydrochloride | Mylan Pharmaceuticals Inc. | 1983-03-15 |
| 00378-0614-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0614-01) | Thioridazine Hydrochloride | Mylan Pharmaceuticals Inc. | 1983-03-15 |
| 00378-0616-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0616-01) | Thioridazine Hydrochloride | Mylan Pharmaceuticals Inc. | 1983-03-15 |
| 00378-0618-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0618-01) | Thioridazine Hydrochloride | Mylan Pharmaceuticals Inc. | 1983-11-18 |
| 48433-0095-20 | 100 BLISTER PACK in 1 CARTON (48433-095-20) / 1 TABLET, FIL... | Thioridazine Hydrochloride | Safecor Health LLC | 2026-02-19 |
| 48433-0096-20 | 100 BLISTER PACK in 1 CARTON (48433-096-20) / 1 TABLET, FIL... | Thioridazine Hydrochloride | Safecor Health LLC | 2026-02-19 |
| 48433-0097-20 | 100 BLISTER PACK in 1 CARTON (48433-097-20) / 1 TABLET, FIL... | Thioridazine Hydrochloride | Safecor Health LLC | 2026-02-19 |
| 48433-0098-20 | 100 BLISTER PACK in 1 CARTON (48433-098-20) / 1 TABLET, FIL... | Thioridazine Hydrochloride | Safecor Health LLC | 2026-02-19 |
| 51079-0565-20 | 100 BLISTER PACK in 1 CARTON (51079-565-20) / 1 TABLET, FIL... | Thioridazine Hydrochloride | Mylan Institutional Inc. | 1998-04-29 |
| 51079-0566-20 | 100 BLISTER PACK in 1 CARTON (51079-566-20) / 1 TABLET, FIL... | Thioridazine Hydrochloride | Mylan Institutional Inc. | 1995-06-12 |
| 51079-0567-20 | 100 BLISTER PACK in 1 CARTON (51079-567-20) / 1 TABLET, FIL... | Thioridazine Hydrochloride | Mylan Institutional Inc. | 1998-05-06 |
| 51079-0580-20 | 100 BLISTER PACK in 1 CARTON (51079-580-20) / 1 TABLET, FIL... | Thioridazine Hydrochloride | Mylan Institutional Inc. | 1998-06-22 |
| 53489-0148-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (53489-148-01) | Thioridazine Hydrochloride | Sun Pharmaceutical Industries, Inc. | 1988-10-07 |
| 53489-0148-10 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (53489-148-10) | Thioridazine Hydrochloride | Sun Pharmaceutical Industries, Inc. | 1988-10-07 |
| 53489-0149-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (53489-149-01) | Thioridazine Hydrochloride | Sun Pharmaceutical Industries, Inc. | 1988-10-07 |
| 53489-0149-10 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (53489-149-10) | Thioridazine Hydrochloride | Sun Pharmaceutical Industries, Inc. | 1988-10-07 |
| 53489-0150-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (53489-150-01) | Thioridazine Hydrochloride | Sun Pharmaceutical Industries, Inc. | 1988-10-07 |
| 53489-0150-10 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (53489-150-10) | Thioridazine Hydrochloride | Sun Pharmaceutical Industries, Inc. | 1988-10-07 |
| 53489-0500-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (53489-500-01) | Thioridazine Hydrochloride | Sun Pharmaceutical Industries, Inc. | 1988-10-07 |
| 53489-0500-02 | 50 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (53489-500-02) | Thioridazine Hydrochloride | Sun Pharmaceutical Industries, Inc. | 1988-10-07 |
| 53489-0500-03 | 250 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (53489-500-03) | Thioridazine Hydrochloride | Sun Pharmaceutical Industries, Inc. | 1988-10-07 |
| 53489-0500-05 | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (53489-500-05) | Thioridazine Hydrochloride | Sun Pharmaceutical Industries, Inc. | 1988-10-07 |
| 53489-0500-06 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (53489-500-06) | Thioridazine Hydrochloride | Sun Pharmaceutical Industries, Inc. | 1988-10-07 |
| 53489-0500-10 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (53489-500-10) | Thioridazine Hydrochloride | Sun Pharmaceutical Industries, Inc. | 1988-10-07 |
| 53489-0500-60 | 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (53489-500-60) | Thioridazine Hydrochloride | Sun Pharmaceutical Industries, Inc. | 1988-10-07 |
| 62135-0934-90 | 90 TABLET, FILM COATED in 1 BOTTLE (62135-934-90) | Thioridazine Hydrochloride | Chartwell RX, LLC | 2025-02-14 |
| 62135-0936-90 | 90 TABLET, FILM COATED in 1 BOTTLE (62135-936-90) | Thioridazine Hydrochloride | Chartwell RX, LLC | 2025-02-14 |
| 62135-0938-90 | 90 TABLET, FILM COATED in 1 BOTTLE (62135-938-90) | Thioridazine Hydrochloride | Chartwell RX, LLC | 2025-02-14 |
| 62135-0939-90 | 90 TABLET, FILM COATED in 1 BOTTLE (62135-939-90) | Thioridazine Hydrochloride | Chartwell RX, LLC | 2025-02-14 |
Observed labelers:
Sun Pharmaceutical Industries, Inc. (13) ·
Chartwell RX, LLC (4) ·
Mylan Institutional Inc. (4) ·
Mylan Pharmaceuticals Inc. (4) ·
Safecor Health LLC (4)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.